Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51


p53 regulates maternal reproduction through LIF.

Hu W, Feng Z, Teresky AK, Levine AJ.

Nature. 2007 Nov 29;450(7170):721-4.


Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.

Garcia-Closas M, Kristensen V, Langerød A, Qi Y, Yeager M, Burdett L, Welch R, Lissowska J, Peplonska B, Brinton L, Gerhard DS, Gram IT, Perou CM, Børresen-Dale AL, Chanock S.

Int J Cancer. 2007 Dec 1;121(11):2532-8.


Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.

Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, Shields PG, Burdette L, Chanock S, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22.


Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population.

Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O'Leary VB, Pangilinan F, Conley M, Cleary L, Brody LC, Scott JM.

Eur J Hum Genet. 2006 Jun;14(6):768-72.


Polymorphisms in the p53 pathway.

Pietsch EC, Humbey O, Murphy ME.

Oncogene. 2006 Mar 13;25(11):1602-11. Review.


Neural tube development requires the cooperation of p53- and Gadd45a-associated pathways.

Patterson AD, Hildesheim J, Fornace AJ Jr, Hollander MC.

Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):129-32.


Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk.

De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V.

J Hum Genet. 2006;51(2):98-103. Epub 2005 Nov 29.


Preventing neural tube defects in Europe: population based study.

Busby A, Abramsky L, Dolk H, Armstrong B; Eurocat Folic Acid Working Group.

BMJ. 2005 Mar 12;330(7491):574-5. No abstract available.


Association of specific genotype and haplotype of p53 gene with cervical cancer in India.

Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S.

J Clin Pathol. 2005 Jan;58(1):26-31.


p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan.

Hsieh LL, Huang TH, Chen IH, Liao CT, Wang HM, Lai CH, Liou SH, Chang JT, Cheng AJ.

Br J Cancer. 2005 Jan 17;92(1):30-5.


A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ.

Cell. 2004 Nov 24;119(5):591-602.


Haploview: analysis and visualization of LD and haplotype maps.

Barrett JC, Fry B, Maller J, Daly MJ.

Bioinformatics. 2005 Jan 15;21(2):263-5. Epub 2004 Aug 5.


A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.

Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutiérrez-Enríquez S, Hall J, Guino E, Peinado MA, Capella G, Canzian F.

Oncogene. 2004 Mar 11;23(10):1954-6.


A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Stephens M, Donnelly P.

Am J Hum Genet. 2003 Nov;73(5):1162-9. Epub 2003 Oct 20.


p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.

Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR.

J Natl Cancer Inst. 2002 May 1;94(9):681-90.


A new statistical method for haplotype reconstruction from population data.

Stephens M, Smith NJ, Donnelly P.

Am J Hum Genet. 2001 Apr;68(4):978-89. Epub 2001 Mar 9.


Surfing the p53 network.

Vogelstein B, Lane D, Levine AJ.

Nature. 2000 Nov 16;408(6810):307-10. No abstract available.


5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

Botto LD, Yang Q.

Am J Epidemiol. 2000 May 1;151(9):862-77. Review.

Items per page

Supplemental Content

Write to the Help Desk